Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer
Clinical trial NCT04466254 · UNKNOWN
Trial details
- NCT number
- NCT04466254
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2021-12-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.